|
12:00 PM
|
--- Lunch & Exhibitor presentations ---
|
|
1:00 PM
|
Novel approaches in imaging
-
Philippe Lambin
(until 2:15 PM)
(2)
|
|
1:00 PM
|
New hypoxia probe development based on mass spectrometry
-
Brad Wouters
(2)
|
|
1:25 PM
|
The role of functional imaging for radiation oncology – The whole translational chain from animals to clinics
-
Esther Troost
(2)
|
|
1:50 PM
|
Is dual energy CT the next standard imaging modality for radiotherapy?
-
Wouter van Elmpt
(2)
|
|
1:00 PM
|
Particle therapy (I)
-
Hirohiko Tsujii
Jürgen Debus
(until 2:15 PM)
(3)
|
|
1:00 PM
|
Proton Radiation Therapy: Current Status at Massachusetts General Hospital
-
Thomas DeLaney
|
|
1:25 PM
|
MedAustron - status and vision
-
Eugen Hug
(3)
|
|
1:50 PM
|
Particle therapy centre in Shanghai
-
Zhen Zhang
(3)
|
|
1:00 PM
|
Proffered papers- clinical
-
Carlo Greco
(until 2:15 PM)
(4)
|
|
1:00 PM
|
Urethra-sparing SBRT for prostate cancer: dosimetric optimization with VMAT vs. IMRT and the learning curve effect
-
Thomas Zilli
(4)
|
|
1:15 PM
|
A novel method to predict a priori the toxicity reduction of a prostate-rectum spacer: Virtual Rectum Spacer
-
Ben Vanneste
(4)
|
|
1:30 PM
|
Local Tumor Flare Following Radiosurgery and Ipilimumab (Ipi) for Melanoma Brain Metastases: Increased Immune Response?
-
Caroline Chung
|
|
1:45 PM
|
Response-based Bayesian Network Approaches for Adaptive Radiotherapy of Non-Small Cell Lung Cancer (NSCLC)
-
Randall Ten Haken
(4)
|
|
2:00 PM
|
Further Development of Spinal Tissue Radiotherapy Re-treatment Modelling, with inclusion of Hadrontherapy
-
Bleddyn Jones
(4)
|
|
2:15 PM
|
Oral poster presentation- Physics/Biology
-
Dag-Rune Olsen
(until 3:45 PM)
(4)
|
|
2:15 PM
|
Proton Minibeam Radiation Therapy (pMBRT): implementation at a clinical center
-
Cécile Peucelle
(4)
|
|
2:25 PM
|
Investigation of the use of inhomogeneous fractional dose distributions in IMPT to improve the therapeutic index
-
Lorenzo Manganaro
(4)
|
|
2:35 PM
|
Accuracy of portal dosimetry in hybrid IMRT and VMAT treatment of the prostate
-
James Bedford
(4)
|
|
2:45 PM
|
ODSH as a countermeasure for radiation-induced thrombocytopenia: Dosimetric studies
-
Stephen Avery
|
|
2:55 PM
|
Measurements of Reactive Oxygen Species production induced by Gold Nanoparticles in Radiotherapy protoco
-
Piergiorgio Cerello
(4)
|
|
3:05 PM
|
NanoxTM: A new multiscale theoretical framework to predict cell survival in the context of particle therapy
-
Micaela Cunha
(4)
|
|
3:15 PM
|
Simulation of cell survival for proton broad and minibeam radiotherapy with hexagonal and square minibeam alignment
-
Matthias Sammer
(4)
|
|
3:25 PM
|
Microbeam Radiation Therapy (MRT): achievements and future perspectives
-
Elke Bräuer-Krisch
(4)
|
|
3:35 PM
|
The role of adipose stromal cells for reversal of radiation fibrosis
-
Fei-Fei Liu
(4)
|
|
2:15 PM
|
Panel discussion
-
Hans Langendijk
Søren Bentzen
(until 3:55 PM)
(3)
|
|
2:15 PM
|
Current and future strategies developed at Paul Scherrer Institute
-
Alessandra Bolsi
(3)
|
|
2:40 PM
|
Optimizing prostate cancer irradiation: from technology to fractionation
-
Raymond Miralbell
(3)
|
|
3:05 PM
|
Technological advancement in radiation oncology
-
Hak Choy
(3)
|
|
3:30 PM
|
Main challenges in adaptive radiotherapy
-
Jan-Jakob Sonke
(3)
|
|
2:15 PM
|
Panel discussion
-
Karin Haustermans
(until 3:55 PM)
(2)
|
|
2:15 PM
|
The Biology of Single Dose Radiotherapy
-
Zvi Fuks
(2)
|
|
2:40 PM
|
Are there common signaling pathways among highly radioresistant tumors? The examples of high grade gliomas and sarcomas
-
Elizabeth Moyal
(2)
|
|
3:05 PM
|
HIF-related therapeutic windows
-
Amato Giaccia
(2)
|
|
3:30 PM
|
Vascular disrupting agents: a new avenue of research
-
Michael Horsman
(2)
|
|
3:55 PM
|
--- Coffee break ---
|
|
4:30 PM
|
Novel strategies to overcome cancer (I): Immunology-based attacks
-
Marce Verheij
(until 5:45 PM)
(2)
|
|
4:30 PM
|
Oncolytic viruses
-
Kevin Harrington
(2)
|
|
4:55 PM
|
Synergy of radiotherapy and cancer vaccines in HPV-positive tumors
-
Eric Deutsch
(2)
|
|
5:20 PM
|
Radiotherapy and the immunocytokine L19-IL2: a perfect match for an abscopal effect with long-lasting memory
-
Ludwig Dubois
(2)
|
|
4:30 PM
|
Novel strategies to overcome cancer (II): Enhancing the ratio between tumor cell killing and normal tissue protection
-
Raymond Miralbell
(until 5:45 PM)
(3)
|
|
4:30 PM
|
Pelvic tumor irradiation: new tools to reduce toxicity: from technology to drugs
-
Karin Haustermans
(3)
|
|
4:55 PM
|
Towards a new type of irradiation
-
Jean Bourhis
|
|
5:20 PM
|
Treatment outcome in patients treated with single-dose irradiation (SDRT) for oligometastatic disease
-
Carlo Greco
(2)
|
|
4:30 PM
|
Proffered papers - Emerging technologies
-
Marco Silari
Vincenzo Patera
(until 5:45 PM)
(4)
|
|
4:30 PM
|
Geometrical interpretation of TOF PET raw data in commercial PET-CT scanner for SNR optimization
-
Chiara Gianoli
(4)
|
|
4:45 PM
|
Characterization and test beam results of a LaBr3 Compton Telescope for treatment monitoring
-
Gabriela Llosá
(4)
|
|
5:00 PM
|
Small Large Momentum Acceptance Gantries for Proton and Carbon Cancer Therapy
-
Dejan Trbojevic
(4)
|
|
5:15 PM
|
X-Ray Phase contrast micro-imaging in neuroscience
-
Giacomo Barbone
|
|
5:30 PM
|
Water based 3D optical dose imaging for particle therapy
-
Oksana Kavatsyuk
|
|
7:00 PM
|
--- Gala dinner with Keynote by Vytenis Andriukaitis, EC Health Commissioner ---
|
